A polymorphism in the CYP17 gene and risk of prostate cancer.

MLA

Stanford, Janet L., et al. “A Polymorphism in the CYP17 Gene and Risk of Prostate Cancer.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 11, no. 3, Mar. 2002, pp. 243–47. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11895872&authtype=sso&custid=ns315887.

APA

Stanford, J. L., Noonan, E. A., Iwasaki, L., Kolb, S., Chadwick, R. B., Feng, Z., & Ostrander, E. A. (2002). A polymorphism in the CYP17 gene and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 11(3), 243–247.

Chicago

Stanford, Janet L, Elizabeth A Noonan, Lori Iwasaki, Suzanne Kolb, Robert B Chadwick, Ziding Feng, and Elaine A Ostrander. 2002. “A Polymorphism in the CYP17 Gene and Risk of Prostate Cancer.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 11 (3): 243–47. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11895872&authtype=sso&custid=ns315887.